Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,208 | 516 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,676 | 109 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,499 | 121 | $0 (2024) |
| Lilly USA, LLC | $614.34 | 39 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $558.90 | 37 | $0 (2024) |
| ABBVIE INC. | $421.98 | 16 | $0 (2024) |
| PFIZER INC. | $386.17 | 26 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $350.35 | 22 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $303.99 | 18 | $0 (2024) |
| Amgen Inc. | $269.96 | 17 | $0 (2024) |
| Abbott Laboratories | $249.82 | 13 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,190 | 53 | GlaxoSmithKline, LLC. ($198.27) |
| 2023 | $1,064 | 65 | GlaxoSmithKline, LLC. ($220.09) |
| 2022 | $1,095 | 59 | Novo Nordisk Inc ($199.51) |
| 2021 | $863.17 | 53 | GlaxoSmithKline, LLC. ($241.92) |
| 2020 | $705.54 | 52 | Novo Nordisk Inc ($272.17) |
| 2019 | $1,107 | 82 | Novo Nordisk Inc ($442.21) |
| 2018 | $1,059 | 74 | GlaxoSmithKline, LLC. ($175.71) |
| 2017 | $1,123 | 78 | Novo Nordisk Inc ($246.80) |
All Payment Transactions
516 individual payment records from CMS Open Payments — Page 1 of 21
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.02 | General |
| Category: Obesity | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.34 | General |
| Category: Diabetes | ||||||
| 12/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: Inflammation | ||||||
| 12/02/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Bone Health | ||||||
| 11/21/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.97 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 11/12/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: Respiratory | ||||||
| 10/14/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/17/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $141.89 | General |
| 09/10/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $21.75 | General |
| Category: Diabetes | ||||||
| 09/09/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.33 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/28/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.54 | General |
| Category: Inflammation | ||||||
| 08/26/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 08/21/2024 | Aroa Biosurgery Incorporated | — | Food and Beverage | Cash or cash equivalent | $44.61 | General |
| 08/12/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $17.09 | General |
| Category: Endocrinology | ||||||
| 08/07/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.42 | General |
| Category: Diabetes | ||||||
| 07/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.57 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: NEUROSCIENCE | ||||||
| 07/18/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.80 | General |
| Category: RESPIRATORY | ||||||
| 07/15/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 06/28/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $16.50 | General |
| Category: Diabetes | ||||||
| 06/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $16.70 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 06/12/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $32.49 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 31 | 2,792 | 4,481 | $965,905 | $303,679 |
| 2022 | 35 | 2,838 | 4,729 | $693,492 | $322,315 |
| 2021 | 35 | 3,145 | 5,003 | $654,620 | $320,058 |
| 2020 | 37 | 3,687 | 6,284 | $617,350 | $342,722 |
All Medicare Procedures & Services
144 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 584 | 1,522 | $406,385 | $135,398 | 33.3% |
| 95923 | Testing of autonomic (sympathetic) nervous system function | Office | 2023 | 314 | 316 | $114,144 | $29,750 | 26.1% |
| 95921 | Testing of autonomic nervous system function and heart rate response to deep breathing | Office | 2023 | 314 | 316 | $80,617 | $20,116 | 25.0% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 41 | 195 | $54,405 | $16,132 | 29.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 98 | 98 | $21,234 | $12,680 | 59.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 135 | 135 | $45,472 | $11,072 | 24.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 140 | 207 | $20,989 | $9,097 | 43.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 94 | 131 | $26,109 | $8,565 | 32.8% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Office | 2023 | 39 | 129 | $27,348 | $7,422 | 27.1% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 27 | 34 | $17,143 | $7,419 | 43.3% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 35 | 87 | $24,273 | $7,418 | 30.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 45 | 52 | $16,774 | $7,089 | 42.3% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 43 | 49 | $24,990 | $7,087 | 28.4% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 26 | 28 | $11,221 | $4,615 | 41.1% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 34 | 56 | $15,120 | $3,626 | 24.0% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 27 | 28 | $11,088 | $2,930 | 26.4% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 27 | 43 | $9,116 | $2,605 | 28.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 159 | 242 | $10,784 | $2,294 | 21.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 135 | 139 | $4,771 | $1,293 | 27.1% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 61 | 122 | $4,899 | $1,197 | 24.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 32 | 32 | $1,600 | $1,010 | 63.1% |
| 93922 | Ultrasound study of arm and leg arteries | Office | 2023 | 12 | 13 | $1,622 | $833.68 | 51.4% |
| 69210 | Removal of impacted ear wax | Office | 2023 | 17 | 20 | $4,473 | $749.36 | 16.8% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 17 | $1,084 | $646.68 | 59.6% |
| 90688 | Influenza vaccine, quadrivalent, 0.5 ml dosage | Office | 2023 | 30 | 30 | $1,722 | $613.80 | 35.6% |
About Dr. Jerilee Lomas, D.O
Dr. Jerilee Lomas, D.O is a Internal Medicine healthcare provider based in Lehigh Acres, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093889529.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jerilee Lomas, D.O has received a total of $8,208 in payments from pharmaceutical and medical device companies, with $1,190 received in 2024. These payments were reported across 516 transactions from 43 companies. The most common payment nature is "Food and Beverage" ($8,208).
As a Medicare-enrolled provider, Lomas has provided services to 12,462 Medicare beneficiaries, totaling 20,497 services with total Medicare billing of $1.3M. Data is available for 4 years (2020–2023), covering 144 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Lehigh Acres, FL
- Active Since 11/17/2006
- Last Updated 03/13/2017
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093889529
Products in Payments
- Ozempic (Drug) $1,021
- TRELEGY ELLIPTA (Drug) $878.56
- FARXIGA (Drug) $456.01
- ANORO (Drug) $350.25
- MOUNJARO (Drug) $295.15
- ENTRESTO (Drug) $273.93
- XARELTO (Drug) $260.04
- Victoza (Drug) $215.32
- ELIQUIS (Drug) $196.93
- ANORO ELLIPTA (Drug) $188.51
- UBRELVY (Drug) $167.91
- Rybelsus (Drug) $164.38
- JARDIANCE (Drug) $149.09
- NURTEC ODT (Drug) $144.76
- Kerendia (Drug) $135.76
- QULIPTA (Drug) $129.68
- DALVANCE (Drug) $124.37
- Tresiba (Drug) $121.43
- Dexcom G6 Transmitter (Medical Supply) $121.22
- Otezla (Drug) $116.10
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Lehigh Acres
Pedro Ylisastigui, M.d, M.D
Internal Medicine — Payments: $25,105
Dr. Edgardo Castillo-Nieves, Md, MD
Internal Medicine — Payments: $10,628
Gautham Mogilishetty, M.d, M.D
Internal Medicine — Payments: $2,871
Dolores Delgado, Md, MD
Internal Medicine — Payments: $2,791
Warlyn Sosa Popoteur, Md, MD
Internal Medicine — Payments: $895.00
Shikha Shrestha, Md, MD
Internal Medicine — Payments: $864.53